|
|
Standards & Ethics
-
Salugen’s nutrigenomics laboratory operates within a framework of the highest laboratory standards worldwide.
Operating within a 15,000 square foot facility, Salugen’s laboratory tests are performed in a high-complexity, CLIA-certified laboratory located in Los Angeles, CA USA. Salugen’s nutrigenomics laboratory partner is certified by the College of American Pathology and the State of California. The laboratory is GLP-certified (Good Laboratory Practices) as well, and is comparable to the world’s leading clinical reference laboratories.
Salugen Chief Scientific Officer, Dr. Kenneth Blum, is the former Director of the Laboratory of Pharmacogenetics at the University of Texas Health Sciences Center in San Antonio, TX USA.
-
Salugen’s manufacturing exceeds practices established by the FDA.
Salugen’s products are manufactured in a pharmaceutical-grade 80,000 square foot facility in Phoenix, AZ USA. Salugen’s manufacturing passes USP inspections (United States Pharmacopeia) and our standard operating procedures comply and exceed GMP (Good Manufacturing Practices) of the United States Department of Health and Human Services Food and Drug Administration (FDA).
Another important aspect of Salugen’s manufacturing are green manufacturing processes. As Salugen develops innovative natural technologies to deliver DNA-customized nutritional solutions, our manufacturing facility operates under a global earth charter to protect our environment and conserve resources. No alcohol or harsh chemicals are used in our manufacturing processes. We only use recyclable glass bottles, organic cotton packaging, and recycled/recyclable paper labels printed with soy-based inks. This manufacturing facility is cleaned with environmentally-friendly bio-cleansers and enzymes instead of chemicals. Solar panels heat the water in the facility, a non-freon system provides air conditioning, and ceramic coating developed by the U.S. space agency, NASA, protects our manufacturing plant from excess heat.
-
Salugen invests an industry leading 20% of net sales into research and development.
Like leading pharmaceutical and biotechnology companies Eli Lilly & Company, Amgen, and Pfizer, Salugen invests 20% of net sales into research & development of its products and those of affiliated companies. Salugen is committed to discovering new personalized medicine technologies to improve the health of consumers worldwide who suffer from the leading healthcare conditions affecting people’s lives. Salugen is currently designing and initiating clinical studies to analyze genetic and metabolic influences on complementary and traditional medicines. With thousands of published studies supporting the genes and ingredients in Salugen's products, Salugen is committed to further researching the correlations between genes and nutrients.
-
Salugen’s scientific approach means no consumer ever takes a Salugen product without having a laboratory test performed first.
Compared to the “trial and error” approach of most nutraceuticals and pharmaceuticals, Salugen is truly defining individualized medicine. Yes, Salugen products are not required to be approved by the FDA and thus do not have years of double-blinded, randomized, placebo-controlled clinical trials that are statistically powered to “try” and account for the variations in the patient population. As we have observed in recent years with the withdrawals of leading COX-2 pharmaceuticals, no amount of these studies can “statistically” predict the result when a consumer puts a pill in their mouth.
Salugen takes a much more scientific approach at the point of care and point of consumption when a consumer elects to take a complementary and alternative medicine. At Salugen, we analyze a person’s DNA for specific genes and then deliver a DNA-customized solution. With this added quality and analysis, Salugen significantly reduces the “guesswork” that is incumbent with traditional nutraceuticals and pharmaceuticals. The question: “Will this work for me?” can be answered through Salugen’s proprietary “Made for Me” process.*
-
Salugen products strictly adhere to the laws and regulations of the countries where products are available, such as within the U.S. where they are classified as nutritional supplements not requiring FDA approval.
Salugen is focused on complementary and alternative medicines which are regulated by a different set of rules in the United States, the European Union, and throughout Asia than traditional medicine. In the United States, these products are governed by a piece of legislation called DSHEA passed in 1994 that do not require approval from the Food and Drug Administration. In Europe and Asia, there are different sets of rules. Consequently, Salugen products are formulated differently based upon the laws of the countries where the consumer purchases our products.
|
Learn More About
|